On the public citation graph

Applying Lipidomics to Non-Alcoholic Fatty Liver Disease: A Clinical Perspective

0 signed · 122 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/bies.201300084openalex-snapshot
The Warburg effect then and now: From cancer to inflammatory diseases
inferredcites →https://doi.org/10.1002/cam4.4317openalex-snapshot
Identification of a glycolysis‐related gene signature for survival prediction of ovarian cancer patients
inferredcites →https://doi.org/10.1002/ejlt.200405001openalex-snapshot
A comprehensive classification system for lipids
inferredcites →https://doi.org/10.1002/hep.21763openalex-snapshot
A lipidomic analysis of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.23810openalex-snapshot
The Biliary HCO3 − Umbrella: A Unifying Hypothesis on Pathogenetic and Therapeutic Aspects of Fibrosing Cholangiopathies
inferredcites →https://doi.org/10.1002/hep.28123openalex-snapshot
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
inferredcites →https://doi.org/10.1002/hep.28289openalex-snapshot
Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1002/hep.29367openalex-snapshot
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
inferredcites →https://doi.org/10.1002/hep.31391openalex-snapshot
Lipid Remodeling in Hepatocyte Proliferation and Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1002/hep4.1188openalex-snapshot
Metabolomic‐based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts
inferredcites →https://doi.org/10.1002/mas.21804openalex-snapshot
Advances in mass spectrometry imaging for spatial cancer metabolomics
inferredcites →https://doi.org/10.1002/mnfr.201900385openalex-snapshot
Industrial Trans Fatty Acids Stimulate SREBP2‐Mediated Cholesterogenesis and Promote Non‐Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1006/geno.1997.5184openalex-snapshot
Genomic DNA Sequence, Promoter Expression, and Chromosomal Mapping of Rat Muscle Carnitine Palmitoyltransferase I
inferredcites →https://doi.org/10.1006/geno.2002.6845openalex-snapshot
A Novel Brain-Expressed Protein Related to Carnitine Palmitoyltransferase I
inferredcites →https://doi.org/10.1007/978-1-4419-6741-1_13openalex-snapshot
Cancer Treatment Strategies Targeting Sphingolipid Metabolism
inferredcites →https://doi.org/10.1007/s00018-009-0035-1openalex-snapshot
Structural insight into function and regulation of carnitine palmitoyltransferase
inferredcites →https://doi.org/10.1007/s00018-018-2860-6openalex-snapshot
Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.bbalip.2011.06.009openalex-snapshot
Lipid classification, structures and tools
inferredcites →https://doi.org/10.1016/j.bbalip.2016.08.014openalex-snapshot
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.cell.2012.02.017openalex-snapshot
Mechanisms for Insulin Resistance: Common Threads and Missing Links
inferredcites →https://doi.org/10.1016/j.chemphyslip.2008.02.007openalex-snapshot
Docosahexaenoic acid (DHA) and hepatic gene transcription
inferredcites →https://doi.org/10.1016/j.chroma.2015.01.013openalex-snapshot
Ultra-high-performance liquid chromatography electrospray ionization tandem mass spectrometry for accurate analysis of glycerophospholipids and sphingolipids in drug resistance tumor cells
inferredcites →https://doi.org/10.1016/j.clnu.2017.08.031openalex-snapshot
Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH – Proteomic and lipidomic insight
inferredcites →https://doi.org/10.1016/j.cmet.2022.09.023openalex-snapshot
The role of lipids in cancer progression and metastasis
inferredcites →https://doi.org/10.1016/j.diabet.2023.101432openalex-snapshot
Concise review of lipidomics in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.ebiom.2021.103661openalex-snapshot
The Altered Serum Lipidome and its Diagnostic Potential for Non-Alcoholic Fatty Liver (NAFL)-Associated Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2019.05.029openalex-snapshot
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.freeradbiomed.2021.06.024openalex-snapshot
Ethnicity-specific alterations of plasma and hepatic lipidomic profiles are related to high NAFLD rate and severity in Hispanic Americans, a pilot study
inferredcites →https://doi.org/10.1016/j.hbpd.2021.05.008openalex-snapshot
LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver
inferredcites →https://doi.org/10.1016/j.jhep.2007.01.030openalex-snapshot
Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: In vitro and in vivo experiments
inferredcites →https://doi.org/10.1016/j.jhep.2016.01.002openalex-snapshot
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.jhep.2017.09.012openalex-snapshot
Association between non-alcoholic fatty liver disease and cancer incidence rate
inferredcites →https://doi.org/10.1016/j.jhep.2017.11.014openalex-snapshot
Lipotoxicity and the gut-liver axis in NASH pathogenesis
inferredcites →https://doi.org/10.1016/j.jhep.2021.04.013openalex-snapshot
Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.jmb.2005.09.097openalex-snapshot
An Intronic Peroxisome Proliferator-activated Receptor-binding sequence Mediates Fatty Acid Induction of the Human Carnitine Palmitoyltransferase 1A
inferredcites →https://doi.org/10.1016/j.mce.2010.05.019openalex-snapshot
Peroxisome proliferator activated receptor α (PPARα) and PPAR gamma coactivator (PGC-1α) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements
inferredcites →https://doi.org/10.1016/j.metabol.2013.10.009openalex-snapshot
Palmitate-induced Activation of Mitochondrial Metabolism Promotes Oxidative Stress and Apoptosis in H4IIEC3 Rat Hepatocytes
inferredcites →https://doi.org/10.1016/j.metabol.2019.154005openalex-snapshot
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
inferredcites →https://doi.org/10.1016/j.plipres.2012.11.002openalex-snapshot
Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis
inferredcites →https://doi.org/10.1016/j.semcancer.2022.02.004openalex-snapshot
The altered lipidome of hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.tibs.2015.12.001openalex-snapshot
The Warburg Effect: How Does it Benefit Cancer Cells?
inferredcites →https://doi.org/10.1016/s0014-5793(98)00744-3openalex-snapshot
The multidrug resistance modulator SDZ PSC 833 is a potent activator of cellular ceramide formation
inferredcites →https://doi.org/10.1021/acs.analchem.7b05215openalex-snapshot
Spatial Systems Lipidomics Reveals Nonalcoholic Fatty Liver Disease Heterogeneity
inferredcites →https://doi.org/10.1021/ja029029oopenalex-snapshot
Polyunsaturated Docosahexaenoic vs Docosapentaenoic AcidDifferences in Lipid Matrix Properties from the Loss of One Double Bond
inferredcites →https://doi.org/10.1038/ncomms14859openalex-snapshot
Pharmacological inhibition of adipose triglyceride lipase corrects high-fat diet-induced insulin resistance and hepatosteatosis in mice
inferredcites →https://doi.org/10.1038/nrc3398openalex-snapshot
Ceramide-orchestrated signalling in cancer cells
inferredcites →https://doi.org/10.1038/nrendo.2017.91openalex-snapshot
SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
inferredcites →https://doi.org/10.1038/s12276-022-00838-5openalex-snapshot
Measurement of lipid flux to advance translational research: evolution of classic methods to the future of precision health
inferredcites →https://doi.org/10.1038/s41418-019-0356-zopenalex-snapshot
SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity
inferredcites →https://doi.org/10.1038/s41419-020-03003-wopenalex-snapshot
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
inferredcites →https://doi.org/10.1038/s41423-022-00872-3openalex-snapshot
Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver
inferredcites →https://doi.org/10.1038/s41575-020-00381-6openalex-snapshot
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
inferredcites →https://doi.org/10.1038/s41598-018-31865-wopenalex-snapshot
Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome
inferredcites →https://doi.org/10.1038/s41598-018-31953-xopenalex-snapshot
Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2
inferredcites →https://doi.org/10.1038/srep46658openalex-snapshot
Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
inferredcites →https://doi.org/10.1042/0300-5127:0290310openalex-snapshot
Regulation of liver carnitine palmitoyltransferase I gene expression by hormones and fatty acids
inferredcites →https://doi.org/10.1053/j.gastro.2007.04.061openalex-snapshot
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
inferredcites →https://doi.org/10.1053/j.gastro.2013.01.054openalex-snapshot
Integrated Metabolite and Gene Expression Profiles Identify Lipid Biomarkers Associated With Progression of Hepatocellular Carcinoma and Patient Outcomes
inferredcites →https://doi.org/10.1053/j.gastro.2015.12.037openalex-snapshot
Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes
inferredcites →https://doi.org/10.1053/j.gastro.2016.03.008openalex-snapshot
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1073/pnas.96.13.7473openalex-snapshot
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
inferredcites →https://doi.org/10.1093/nar/gkl838openalex-snapshot
LMSD: LIPID MAPS structure database
inferredcites →https://doi.org/10.1096/fj.201601393ropenalex-snapshot
Defective lysosomal clearance of autophagosomes and its clinical implications in nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/apt.15192openalex-snapshot
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non‐alcoholic fatty liver disease; the importance of an elevated mean platelet volume
inferredcites →https://doi.org/10.1111/apt.16066openalex-snapshot
Circulating lipidomic alterations in obese and non‐obese subjects with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/hepr.13528openalex-snapshot
Metabolomic/lipidomic‐based analysis of plasma to diagnose hepatocellular ballooning in patients with non‐alcoholic fatty liver disease: A multicenter study
inferredcites →https://doi.org/10.1111/j.1742-7843.2007.00199.xopenalex-snapshot
Chemosensitivity Determinants of Irinotecan Hydrochloride in Hepatocellular Carcinoma Cell Lines
inferredcites →https://doi.org/10.1111/liv.13502openalex-snapshot
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
inferredcites →https://doi.org/10.1111/liv.14857openalex-snapshot
SPARC inhibition accelerates NAFLD‐associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
inferredcites →https://doi.org/10.1126/science.1204265openalex-snapshot
Human Fatty Liver Disease: Old Questions and New Insights
inferredcites →https://doi.org/10.1126/scisignal.2000446openalex-snapshot
EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway Sensitizes Glioblastomas to Antilipogenic Therapy
inferredcites →https://doi.org/10.1136/gutjnl-2012-302962openalex-snapshot
Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1136/gutjnl-2019-319664openalex-snapshot
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
inferredcites →https://doi.org/10.1152/ajpcell.00123.2022openalex-snapshot
Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1152/ajpendo.00492.2015openalex-snapshot
Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity
inferredcites →https://doi.org/10.1158/2159-8290.cd-11-0102openalex-snapshot
An LXR Agonist Promotes Glioblastoma Cell Death through Inhibition of an EGFR/AKT/SREBP-1/LDLR–Dependent Pathway
inferredcites →https://doi.org/10.1159/000525911openalex-snapshot
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease
inferredcites →https://doi.org/10.1172/jci.insight.132158openalex-snapshot
Hydroxysteroid 17-β dehydrogenase 13 variant increases phospholipids and protects against fibrosis in nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1172/jci0215593openalex-snapshot
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
inferredcites →https://doi.org/10.1172/jci15593openalex-snapshot
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
inferredcites →https://doi.org/10.1172/jci28898openalex-snapshot
TLR4 links innate immunity and fatty acid–induced insulin resistance
inferredcites →https://doi.org/10.1172/jci6223openalex-snapshot
Peroxisome proliferator–activated receptor α mediates the adaptive response to fasting
inferredcites →https://doi.org/10.1177/0004563218817798openalex-snapshot
Bile acids and the metabolic syndrome
inferredcites →https://doi.org/10.1177/107327480301000207openalex-snapshot
Overcoming Multidrug Resistance in Cancer: An Update on the Clinical Strategy of Inhibiting P-Glycoprotein
inferredcites →https://doi.org/10.1186/s12986-018-0288-5openalex-snapshot
Changes in lysophospholipids and liver status after weight loss: the RESMENA study
inferredcites →https://doi.org/10.1186/s40880-018-0301-4openalex-snapshot
Lipid metabolism reprogramming and its potential targets in cancer
inferredcites →https://doi.org/10.1194/jlr.e400004-jlr200openalex-snapshot
A comprehensive classification system for lipids
inferredcites →https://doi.org/10.1194/jlr.m085613openalex-snapshot
Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
inferredcites →https://doi.org/10.1194/jlr.p055640openalex-snapshot
Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1194/jlr.p056002openalex-snapshot
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
inferredcites →https://doi.org/10.1210/endocr/bqz046openalex-snapshot
CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential
inferredcites →https://doi.org/10.1371/journal.pone.0022775openalex-snapshot
Increased Diacylglycerols Characterize Hepatic Lipid Changes in Progression of Human Nonalcoholic Fatty Liver Disease; Comparison to a Murine Model
inferredcites →https://doi.org/10.14800/ics.1561openalex-snapshot
Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury
inferredcites →https://doi.org/10.18632/oncotarget.23494openalex-snapshot
Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
inferredcites →https://doi.org/10.2174/13816128113199990486openalex-snapshot
Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
inferredcites →https://doi.org/10.2174/1381612825666190117102111openalex-snapshot
Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
inferredcites →https://doi.org/10.3322/caac.21708openalex-snapshot
Cancer statistics, 2022
inferredcites →https://doi.org/10.3390/cells8030277openalex-snapshot
A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver
inferredcites →https://doi.org/10.3390/cells9040875openalex-snapshot
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
inferredcites →https://doi.org/10.3390/diagnostics11061083openalex-snapshot
Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity Study
inferredcites →https://doi.org/10.3390/ijms18122550openalex-snapshot
Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
inferredcites →https://doi.org/10.3390/ijms21010040openalex-snapshot
Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
inferredcites →https://doi.org/10.3390/ijms21186799openalex-snapshot
NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling
inferredcites →https://doi.org/10.3390/ijms22094495openalex-snapshot
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
inferredcites →https://doi.org/10.3390/ijms23095146openalex-snapshot
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
inferredcites →https://doi.org/10.3390/ijms24043563openalex-snapshot
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.3748/wjg.v25.i24.3009openalex-snapshot
Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4779244openalex-extracted
Dietary Nicotinamide Improves Growth Performance and Ameliorates Liver Lipidome Profiles by Alleviating Glycerophospholipid and Sphingolipids Metabolism in Swamp Eel (Monopterus Albus)
inferred← citeshttps://doi.org/10.2139/ssrn.4791782openalex-extracted
Dietary Nicotinamide Improves Growth Performance and Ameliorates Liver Lipid Profiles by Alleviating Glycerophospholipid and Sphingolipids Metabolism in Swamp Eels (Monopterus Albus)
inferred← citeshttps://doi.org/10.2139/ssrn.4873690openalex-extracted
Dietary Nicotinamide Improves Growth Performance and Ameliorates Liver Lipid Profiles by Alleviating Glycerophospholipid and Sphingolipids Metabolism in Swamp Eel (Monopterus Albus)
inferred← citeshttps://doi.org/10.1002/mnfr.202200525openalex-snapshot
Comparative Lipidomics and Metabolomics Reveal the Underlying Mechanisms of Taurine in the Alleviation of Nonalcoholic Fatty Liver Disease Using the Aged Laying Hen Model
inferred← citeshttps://doi.org/10.1007/s11306-025-02292-6openalex-snapshot
Mapping current research status and emerging frontiers of lipidomics: a comprehensive data-mining-based study
inferred← citeshttps://doi.org/10.1016/j.aqrep.2024.102361openalex-snapshot
Dietary nicotinamide improves growth performance and ameliorates liver lipid profiles by alleviating glycerophospholipid and sphingolipids metabolism in swamp eel (Monopterus albus)
inferred← citeshttps://doi.org/10.1016/j.biochi.2023.09.020openalex-snapshot
Impaired hepatic lipid metabolism and biomarkers in fatty liver disease
inferred← citeshttps://doi.org/10.1021/acs.est.4c00421openalex-snapshot
Bis(2-ethylhexyl)-2,3,4,5-tetrabromophthalate Enhances foxo1-Mediated Lipophagy to Remodel Lipid Metabolism in Zebrafish Liver
inferred← citeshttps://doi.org/10.1021/acsnutrsci.5c00023openalex-snapshot
Distinct Effects of Dietary Phosphatidylinositol and myo -Inositol on Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice
inferred← citeshttps://doi.org/10.1038/s41598-025-15778-zopenalex-snapshot
Characterizing plasma lipid species in metabolic dysfunction associated steatotic liver disease in persons with type 1 diabetes
inferred← citeshttps://doi.org/10.1038/s43856-025-01149-2openalex-snapshot
Metabolomics for searching non-invasive biomarkers of metabolic dysfunction-associated steatotic liver disease in youth with vertical HIV
inferred← citeshttps://doi.org/10.1186/s12906-025-04759-4openalex-snapshot
A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty liver disease
inferred← citeshttps://doi.org/10.3389/fmed.2025.1705723openalex-snapshot
Metabolic dysregulation in MASLD-associated HCC: diagnostic biomarkers and therapeutic opportunities
inferred← citeshttps://doi.org/10.3390/nu17111936openalex-snapshot
Lipid Metabolism and Relevance to Chronic Disease
inferred← citeshttps://doi.org/10.3390/nu17243849openalex-snapshot
A Multi-Omics Study Reveals the Active Components and Therapeutic Mechanism of Erhuang Quzhi Formula for Non-Alcoholic Fatty Liver Disease
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.